Journal ArticleAnn Surg Oncol · October 2023
BACKGROUND: Breast-conserving surgery (BCS) is a mainstay for breast cancer management, and obtaining negative margins is critical. Some have advocated for the use of preoperative magnetic resonance imaging (MRI) in reducing positive margins after BCS. We ...
Full textLink to itemCite
Journal ArticleAnn Surg · May 1, 2021
OBJECTIVE: Single-center studies have demonstrated that resection of cavity shave margins (CSM) halves the rate of positive margins and re-excision in breast cancer patients undergoing partial mastectomy (PM). We sought to determine if these findings were ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · April 2021
BACKGROUND: We examined the impact of cavity shave margins (CSMs) on margin status in patients with pure ductal carcinoma in situ (DCIS) undergoing partial mastectomy (PM). METHODS: One hundred and nine patients from 2 multicenter, randomized controlled tr ...
Full textLink to itemCite
Journal ArticleBreast J · November 2020
Nipple-sparing mastectomy (NSM) offers patients who are not candidates for breast-conserving treatment an aesthetically pleasing alternative to traditional mastectomy. Some studies have demonstrated its oncologic safety while others have demonstrated resid ...
Full textLink to itemCite
Journal ArticleBreast J · October 2020
INTRODUCTION: Reported upgrade rate to malignancy of radial scars (RS) ranges widely (0%-40%) making management controversial. METHODS: A retrospective chart review was performed on patients with RS on core needle biopsy (CNB). Upgrade rates to malignancy ...
Full textLink to itemCite
Journal ArticleBreast Cancer Res Treat · June 2020
PURPOSE: Discordance between HER2 expression in tumor tissue (tHER2) and HER2 status on circulating tumor cells (cHER2) has been reported. It remains largely underexplored whether patients with tHER2-/cHER2+ can benefit from anti-HER2 targeted therapies. M ...
Full textLink to itemCite
Journal ArticleEur J Cancer · January 2019
BACKGROUND: Both circulating tumour cell (CTC) and total circulating cell-free DNA (ccfDNA) predict cancer patient prognosis. However, no study has explored the prognostic value of the combined use of CTC and ccfDNA. We aimed to investigate individual and ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · July 2018
BACKGROUND: Positive margins have been reported in 20% to 40% of patients undergoing a partial mastectomy, often resulting in re-excision. How often the re-excision yields additional cancer and whether there are predictors of residual disease remain unknow ...
Full textLink to itemCite
ConferencePlast Reconstr Surg · August 2017
BACKGROUND: Loss of the nipple-areola complex can be psychologically and sexually devastating. Nipple-sparing mastectomy provides robust cosmetic results, but few studies have investigated the quality-of-life outcomes associated with it. METHODS: The autho ...
Full textLink to itemCite
ConferenceAnn Surg · January 2017
OBJECTIVE: The aim of the study was to compare costs associated with excision of routine cavity shave margins (CSM) versus standard partial mastectomy (PM) in patients with breast cancer. BACKGROUND: Excision of CSM reduces re-excision rates by more than 5 ...
Full textLink to itemCite
Journal ArticleBreast · October 2016
The primary aim in the management of DCIS is the prevention of recurrence and contralateral tumor. Risk factors for DCIS recurrence and appropriate treatments are still widely debated. Adjuvant therapies after surgical resection reduce recurrences and cont ...
Full textLink to itemCite
Journal ArticleAm J Surg Pathol · August 2016
Most institutions reflexively test all breast core needle biopsy specimens showing ductal carcinoma in situ (DCIS) for estrogen receptor (ER) and progesterone receptor (PR). However, 5 factors suggest that this reflex testing unnecessarily increases costs. ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · August 2016
BACKGROUND: The management of intraductal papillomas on core biopsy continues to be controversial. Papillomas with atypia are typically excised. However, it is unclear whether surgical excision is warranted for benign lesions. METHODS: A retrospective revi ...
Full textLink to itemCite
Journal ArticleN Engl J Med · August 6, 2015
BACKGROUND: Routine resection of cavity shave margins (additional tissue circumferentially around the cavity left by partial mastectomy) may reduce the rates of positive margins (margins positive for tumor) and reexcision among patients undergoing partial ...
Full textLink to itemCite
Journal ArticleAm J Surg Pathol · July 2015
ER/PR/Her2 are often reflexively assessed in all core needle biopsies (CNBXs) containing invasive mammary carcinoma (IMC) so that neoadjuvant therapy can be considered. ER/PR/Her2 can be heterogenous, and there is growing consensus that negative results fo ...
Full textLink to itemCite
Journal ArticleBreast Cancer Res Treat · November 2014
Many sentinel lymph node biopsies (SLNBs) are evaluated intraoperatively by frozen section, which may impact the need for further axillary dissection (AD). However, the need for AD in patients with small metastases has been recently called into question, m ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · February 2014
BACKGROUND: Recent trials have suggested that axillary node dissection may not be warranted in some breast cancer patients with one to two positive nodes. Given that lymph node ratio (LNR; number of positive lymph nodes divided by the total examined) has b ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · October 2013
BACKGROUND: The identification of distinct molecular subtypes has changed breast cancer management. The correlation between mammographic appearance and molecular subtype for invasive breast cancer has not been extensively studied. METHODS: A retrospective ...
Full textLink to itemCite
Journal ArticleClin Cancer Res · July 15, 2013
PURPOSE: Agents that target the epigenome show activity in breast cancer models. In preclinical studies, the histone deacetylase inhibitor vorinostat induces cell-cycle arrest, apoptosis, and differentiation. We evaluated biomarker modulation in breast can ...
Full textLink to itemCite
Journal ArticleAm J Surg Pathol · June 2013
The differential diagnosis of low-nuclear grade intraductal epithelial proliferations of the breast includes atypical ductal hyperplasia (ADH) and ductal carcinoma in situ (DCIS). This distinction can be difficult on core needle biopsy (CNB) but can have s ...
Full textLink to itemCite
ConferenceAm Surg · June 2013
Little is known about factors influencing time between diagnosis and definitive treatment in patients with ductal carcinoma in situ (DCIS). We sought to determine the factors influencing this delay time and implications on outcome. A retrospective review w ...
Link to itemCite
Journal ArticleSci Transl Med · October 26, 2011
Most breast cancers originate in the epithelial cells lining the breast ducts. Intraductal administration of cancer therapeutics would lead to high drug exposure to ductal cells and eliminate preinvasive neoplasms while limiting systemic exposure. We perfo ...
Full textLink to itemCite
Journal ArticleAcad Radiol · December 2010
RATIONALE AND OBJECTIVES: The aim of this prospective study was to investigate using multiparametric and multinuclear magnetic resonance imaging during preoperative systemic therapy for locally advanced breast cancer. MATERIALS AND METHODS: Women with oper ...
Full textLink to itemCite
Journal ArticleClinical Proteomics · September 1, 2010
Introduction: The objective of this study was to identify cancer-associated protein expression patterns in bilateral matched nipple aspiration fluids using nanoscale reciprocal Cy3/Cy5 labeling and high-content antibody microarrays. This novel platform all ...
Full textCite
Journal ArticleBreast Cancer Res Treat · August 2010
By comparison of mass spectra from a small cohort of nipple aspiration fluids (NAF), we previously discovered a panel of five candidate breast cancer biomarkers among them an unidentified 4.7 kD peptide BF5. The purposes of the present study were to verify ...
Full textLink to itemCite
Journal ArticleAm J Surg Pathol · June 2010
INTRODUCTION: Atypical lobular hyperplasia (ALH), often an incidental finding in breast core biopsies, is largely considered to be a risk factor for carcinoma rather than a direct precursor. However, management of ALH is controversial. We review our experi ...
Full textLink to itemCite
Journal ArticleClinical Breast Cancer · February 1, 2010
Background: Four major clinical trials have established that trastuzumab added to adjuvant systemic chemotherapy for women with HER2+ breast cancer significantly improves disease-free and overall survival compared with chemotherapy alone. We evaluated path ...
Full textCite
Journal ArticleJ Clin Oncol · June 10, 2009
PURPOSE: Anthracyclines and concurrent whole-breast irradiation result in prohibitive cutaneous toxicity. We hypothesized that anthracycline-based chemotherapy and concurrent partial breast irradiation (PBI) is safe and conducted a single-arm feasibility t ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · December 2008
BACKGROUND: Retrospective studies have shown that occult nipple-areolar complex (NAC) involvement in breast cancer is low, occurring in 6-10% of women undergoing skin-sparing mastectomy (SSM). The cosmetic result and high patient satisfaction of nipple-spa ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · May 2008
BACKGROUND: No study has systematically evaluated the significance of involvement of the superficial specimen margin in skin-sparing mastectomies (SSMs). METHODS: 168 SSMs with a small, additional superficial margin (ASM) specimen taken directly over the t ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · February 2008
BACKGROUND: As a complement to sentinel node dissection (SLND), we evaluated ultrasound-guided fine-needle aspiration (USFNA) of normal and abnormal axillary nodes in breast cancer patients. We hypothesized that USFNA would be accurate for primary breast t ...
Full textLink to itemCite
Book · 2008
Breast MRI has paved the way for new thinking regarding the workup of women recently diagnosed with breast cancer and the screening of high-risk women. The routine use of MRI preoperatively is advocated, particularly in young patients and women with dense ...
Full textLink to itemCite
Journal ArticlePlast Reconstr Surg · April 2006
BACKGROUND: Subcutaneous mastectomy for women with advanced breast cancer has been historically controversial because of the increased risk for tumor recurrence. Despite this, some women remain interested in this method of treatment as a means of preservin ...
Full textLink to itemCite
Journal ArticleAm J Surg Pathol · December 2005
In breast conservation therapy, the margin status of the specimen predicts local recurrence and determines the need for reexcision. Many surgeons now take, at the time of lumpectomy, multiple separate "cavity margins" (CM) (the entire wall of the residual ...
Full textLink to itemCite
Journal ArticlePlast Reconstr Surg · February 2005
The advantages of breast reconstruction using the deep inferior epigastric perforator (DIEP) flap and the muscle-sparing free transverse rectus abdominis musculocutaneous (TRAM) flap (MS-2) are well recognized. Both techniques optimize abdominal function b ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · May 15, 2004
PURPOSE: Approximately 5% to 10% of newly diagnosed breast cancer patients carry a BRCA1 or BRCA2 mutation. Given these patients' high risk for contralateral breast cancer, bilateral mastectomy is increasingly considered a treatment option for newly diagno ...
Full textLink to itemCite
Journal ArticlePlast Reconstr Surg · August 2003
The incidence of infection following breast reconstruction with expanders and implants ranges from 1 to 24 percent. Numerous factors associated with infection have been described; however, a one-variable at time setting and multifactorial analysis have not ...
Full textLink to itemCite
Journal ArticleOncology (Williston Park) · August 2003
Over the past 2 decades, breast-conservation therapy with lumpectomy and whole-breast radiotherapy has become a standard option for the majority of women with newly diagnosed breast cancer. Long-term local control is achieved in approximately 85% of patien ...
Link to itemCite
Journal ArticlePlast Reconstr Surg · March 2003
As the inclusion criteria for breast conservation therapy have continued to evolve to include lower quadrant tumors, very large breasts, and central tumors, the potential for significant disfigurement after breast conservation therapy has also increased. T ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · March 1, 2003
PURPOSE: There are few data on sequelae of breast cancer treatments in older women. We evaluated posttreatment quality of life and satisfaction in a national population. PATIENTS AND METHODS: Telephone surveys were conducted with a random cross-sectional s ...
Full textLink to itemCite
Journal ArticleClin Cancer Res · January 2003
INTRODUCTION: Response to neoadjuvant chemotherapy for locally advanced breast cancer can be correlated with long-term outcomes. Surrogate end-point biomarkers may be used to assess response to the treatment. Most reported studies assessed the effects of c ...
Link to itemCite
Journal ArticleCancer · December 15, 2002
BACKGROUND: There are few data on the long-term sequelae of axillary dissection among older breast carcinoma patients. We describe the impact of axillary dissection in a cohort of older women. METHODS: A longitudinal cohort of 571 patients with Stage 1 and ...
Full textLink to itemCite
Journal ArticleCancer · May 15, 2002
BACKGROUND: Axillary dissection for the evaluation and treatment of patients with breast carcinoma often is not performed in older women. The objective of this study was to examine patient, clinical, and surgeon characteristics associated with the use of a ...
Full textLink to itemCite
Journal ArticleClin Cancer Res · May 2002
PURPOSE: Gene expression microarray technologies have the potential to define molecular profiles that may identify specific phenotypes(diagnosis), establish a patient's expected clinical outcome (prognosis), and indicate the likelihood of a beneficial effe ...
Link to itemCite
Journal ArticleAnn Surg Oncol · April 2002
BACKGROUND: After neoadjuvant chemotherapy, women with locally advanced breast cancer (LABC) undergo a modified radical mastectomy or lumpectomy with axillary lymph node dissection (ALND) and radiotherapy. Sentinel lymphadenectomy (SL) is accepted for axil ...
Full textLink to itemCite
Journal ArticleBreast Cancer Res Treat · January 2000
The 78 kDa glucose-regulated stress protein GRP78 is induced by physiological stress conditions such as hypoxia, low pH, and glucose deprivation which often exist in the microenvironments of solid tumors. Activation of this stress pathway occurs in respons ...
Full textLink to itemCite
ConferencePostgraduate Medicine · May 15, 1999
Each year, about 200,000 women in the United States undergo therapy for breast cancer - but are they receiving the most effective treatment? In the past, management focused on aggressive local surgery, but current strategies emphasize earlier systemic trea ...
Full textCite
Journal ArticleSurg Endosc · January 1999
BACKGROUND: Minimally invasive approaches have changed the practice of surgery in several specialties. The purpose of this study was to develop a reproducible endoscopic technique for the evaluation of the axilla in breast cancer patients. METHODS: A total ...
Full textLink to itemCite
Journal ArticleBreast Disease · January 1, 1996
A 21-year-old woman presented with a large, well-circumscribed breast mass. Magnetic resonance imaging (MRI) showed multiple cleftlike, fluid-filled spaces within the mass, a feature described as characteristic of phyllodes tumors. Pathologic examination s ...
Cite
Journal ArticleAnn Surg Oncol · March 1994
BACKGROUND: The finding of lobular carcinoma in situ (LCIS) in the breast has generally prompted treatment with unilateral or bilateral mastectomy. Most experts now feel that LCIS simply identifies a woman who is at high risk to develop future breast cance ...
Full textLink to itemCite
Journal ArticleClin Imaging · 1994
The role of unenhanced breast MRI as an adjunct to mammography in the diagnosis of a breast carcinoma presenting as architectural distortion partially obscured by dense tissue on film-screen mammography is illustrated. ...
Full textLink to itemCite
Journal ArticleBreast Disease · January 1, 1994
Double-lumen saline-silicone implants have been used to decrease fibrotic capsule formation. Some of these patients are being referred for imaging evaluation complementary to mammography for suspected implant abnormalities. Magnetic resonance imaging (MRI) ...
Cite
Journal ArticleRadiology · December 1993
PURPOSE: To ascertain the frequency and pathologic relationships of atypical hyperplasia in biopsy specimens obtained after clinical and mammographic examination. MATERIALS AND METHODS: Clinical, mammographic, and histologic findings were prospectively cor ...
Full textLink to itemCite
Journal ArticleAm J Surg · June 1993
Forty women 30 years of age or less underwent breast biopsy at Roswell Park Cancer Institute between January 1980 and January 1989. Thirty-eight of the 40 women had a palpable breast mass. Thirty-one of these young women had self-detected breast masses, an ...
Full textLink to itemCite
Journal ArticleCancer · March 1, 1993
BACKGROUND: Between 1975 and 1987, 128 patients with infiltrating breast cancer, categorized as clinical Stage I and II disease, were treated by breast conservation surgery without radiation therapy. MATERIALS: After a median disease-free interval of 20 mo ...
Full textLink to itemCite
Journal ArticleSurgical oncology · January 1993
An autopsy series on the patterns of occurrence of second primary non-mammary malignancies (SPNM) in breast cancer patients is presented. SPNM occurred in 11.4% of breast cancer patients at a mean interval of 83.9 months. Seventy-five per cent of them occu ...
Full textCite
Journal ArticleAmerican Journal of Surgery · December 1, 1992
Forty women 30 years of age or less underwent breast biopsy at Roswell Park Cancer Institute between January 1980 and January 1989. Thirty-eight of the 40 women had a palpable breast mass. Thirty-one of these young women had self-detected breast masses, an ...
Cite
Journal ArticleRadiology · November 1992
Eighty consecutive biopsy specimens were studied to determine whether DNA analysis could be performed on fine-needle aspirates of excised clinically occult breast lesions obtained under guidance with mammography of the specimen before fixation to offer the ...
Full textLink to itemCite
Journal ArticleSurg Oncol · October 1992
Patients presenting with locally advanced breast cancer (LABC) constitute a diverse group for which a variety of treatment modalities have been instituted. To assess which factors have a direct impact on outcome, we reviewed the medical records of 104 pati ...
Full textLink to itemCite
Journal ArticleCancer · February 15, 1992
To ascertain the prognostic significance of tumor hormone receptor status in premenopausal patients with node-negative breast cancer, a retrospective review of 199 patients who met these criteria was conducted. Of these 199 patients, estrogen receptor (ER) ...
Full textLink to itemCite
Journal ArticleAm J Surg · September 1991
A review was undertaken of 226 patients with primary breast carcinoma who were 35 years of age, or younger, from 1960 to 1987. Comparisons to other studies of young and older women were made for clinical, pathologic, and survival characteristics. Young pat ...
Full textLink to itemCite